Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Menu

    DSSTox_CID_3322

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,659Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Corcept Faces Teva Lawsuit Over Mifepristone 'Monopoly'
    Corcept Faces Teva Lawsuit Over Mifepristone 'Monopoly'

    15 Sep 2025

    // REUTERS

    https://www.reuters.com/legal/litigation/drugmaker-corcept-must-face-teva-lawsuit-over-mifepristone-monopoly-rare-2025-09-15/

    REUTERS
    15 Sep 2025
    Share Share
    Biotech Leaders, Investors urge FDA to Preserve Access
    Biotech Leaders, Investors urge FDA to Preserve Access

    03 Jul 2025

    // BIOSPACE

    https://www.biospace.com/policy/biotech-leaders-investors-ask-fda-to-maintain-access-to-mifepristone

    BIOSPACE
    03 Jul 2025
    Share Share
    Biotech Leaders Urge FDA to Not Restrict Abortion Pill Access
    Biotech Leaders Urge FDA to Not Restrict Abortion Pill Access

    02 Jul 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/more-50-biotech-leaders-urge-fda-not-restrict-mifepristone-access

    FIERCE BIOTECH
    02 Jul 2025
    Share Share
    Four States Ask FDA to Lift Restrictions on Mifepristone
    Four States Ask FDA to Lift Restrictions on Mifepristone

    07 Jun 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/response-fda-review-mifepristone-4-pro-abortion-states-fire-back

    FIERCE PHARMA
    07 Jun 2025
    Share Share
    Abortion pill ruling offers measure of relief for FDA, biotech
    Abortion pill ruling offers measure of relief for FDA, biotech

    17 Jun 2024

    // Delilah Alvarado BIOPHARMADIVE

    https://www.biopharmadive.com/news/supreme-court-mifepristone-biotech-fda-impact/719059/

    Delilah Alvarado BIOPHARMADIVE
    17 Jun 2024
    Share Share
    US Supreme Court preserves access to abortion pill mifepristone
    US Supreme Court preserves access to abortion pill mifepristone

    14 Jun 2024

    // Andrew Chung REUTERS

    https://www.reuters.com/legal/us-supreme-court-will-not-restrict-access-abortion-pill-2024-06-13/

    Andrew Chung REUTERS
    14 Jun 2024
    Share Share